Skip to main content

Find Clinical Trials

Home
Conditions
Uterine Neoplasms

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,267 public trials 572 recruiting studies

Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Completed

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening

NCT00479375

Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia, Female Urogenital Diseases, +14 more
Locations: Malmo University Hospital Malmö, Sweden

View Trial Details

Completed

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

NCT00190697

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +22 more
Locations: For information regarding investigative sites for this clinical trial, call 1-877- CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or contact your personal physician Houston, Texas, United States

View Trial Details

Completed

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

NCT00404326

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: National Institute of Cancerologia Mexico City, TLALPAN, Mexico

View Trial Details

Completed

Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors

NCT00010829

Conditions: Bone Diseases, Bone Diseases, Metabolic, Breast Cancer, +22 more
Locations: Columbia University New York, United States

View Trial Details

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations: University of Arizona, VA Medical Center Tucson, Arizona, United States

Detroit Medical Center, Wayne State University Detroit, Michigan, United States

East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States

University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions: Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations: Arizona Oncology Associates Tucson, Arizona, United States

Rocky Mountain Cancer Centers Aurora, Colorado, United States

St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States

View all 17 locations

View Trial Details

Withdrawn

CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

NCT07090174

Conditions: Acquired Immunodeficiency Syndrome, Anal Cancer, Anus Diseases, +40 more
Locations: Weill Cornell Medical College New York, United States

Montefiore Medical Center/Albert Einstein College of Medicine The Bronx, New York, United States

University of Puerto Rico San Juan, Puerto Rico

View Trial Details